Angiomax (Bivalirudin) – Teva drops attempts to void Angiomax patents, but will supply Medicines Company with the active ingredient (The IP Factor) (GenericsWeb)

US: Rep. McCaul seeks to reinvigorate interest in the Creating Hope Act of 2011; introduces companion bill in the House (FDA Law Blog)

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.